The haploidentical option for high-risk haematological malignancies

Blood Cells, Molecules, and Diseases

Volumn 40, Issue 1, 2008, Pages 8-12

  Aversa, Franco ^a   Reisner, Yair ^b   Martelli, Massimo F ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Haploidentical transplant; High risk acute leukaemia; Megadose of CD34+ cells; NK cell alloreactivity

Indexed keywords

CD34 ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER RISK; CHILD; CONTROLLED STUDY; CONVALESCENCE; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HAPLOIDY; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; T CELL DEPLETION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; LEUKEMIA; LEUKEMIA, MYELOID, ACUTE; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 36548999731     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2007.07.004     Document Type: Article

References (16)

1. Ruggeri L., Capanni M., Casucci M., Volpi I., Tosti A., Perruccio K., et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 94 (1999) 333-339
2. Velardi A., Ruggeri L., and Allessandro Moretta L. NK cells: a lesson from mismatched hematopoietic transplantation. Trends Immunol. 23 (2002) 438-444
3. Ruggeri L., Capanni M., Urbani E., Perruccio K., Shlomchik W.D., Tosti A., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295 (2002) 2097-2100
4. Bachar-Lustig E., Rachamim N., Li H.W., Lan F., and Reisner Y. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat. Med. 1 (1995) 1268-1273
5. Aversa F., Tabilio A., Terenzi A., Velardi A., Falzetti F., Giannoni C., et al. Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 84 (1994) 3948-3955
6. Aversa F., Tabilio A., Velardi A., Cunningham I., Terenzi A., Falzetti F., et al. Treatment of high risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N. Engl. J. Med. 339 (1998) 1186-1193
7. Aversa F., Terenzi A., Tabilio A., Falzetti F., Carotti A., Ballanti S., et al. Full-haplotype mismatched hematopoietic stem cell transplantation: a phase II study in patients with acute leukemia at high risk or relapse. J. Clin. Oncol. 23 (2005) 3447-3454
8. Meijer E., Slaper-Cortenbach I.C., Thijsen S.F., Dekker A.W., and Verdonck L.F. Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique. Bone Marrow Transplant. 29 (2002) 335-339
9. Liu D., Tammik C., Zou J.Z., Ernberg I., Masucci M.G., Ringden O., and Levitsky V. Effect of combined T- and B-cell depletion of allogeneic HLA-mismatched bone marrow graft on the magnitude and kinetics of Epstein-Barr virus load in the peripheral blood of bone marrow transplant recipients. Clin. Transplant. 18 (2004) 518-524
10. Terenzi A., Aristei C., Aversa F., Perruccio K., Chionne F., Raymondi C., et al. Efficacy of fludarabine as an immunosuppressor for bone marrow transplantation conditioning: Preliminary results. Transplant. Proc. 28 (1996) 3101
11. Volpi I., Perruccio K., Tosti A., Capanni M., Ruggeri L., Posati S., et al. Post-grafting granulocyte colony-stimulating factor administration impairs functional immune recovery in recipients of HLA haplotype-mismatched hematopoietic transplants. Blood 97 (2001) 2514-2521
12. Russell J.A., Turner A.R., Larratt L., Chaudhry A., Morris D., Brown C., et al. Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis. Biol. Blood Marrow Transplant. 13 (2007) 299-306
13. Waller E.K., Langston A.A., Lonial S., Cherry J., Somani J., Allen A.J., et al. Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation. Biol. Blood Marrow Transplant. 9 (2003) 460-471
14. Ruggeri L., Mancusi A., Capanni M., Urbani E., Carotti A., Aloisi T., et al. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood 110 (2007) 433-440
15. Ruggeri L., Mancusi A., Burchielli E., Aversa F., Martelli M.F., and Velardi A. Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. Curr. Opin. Oncol. 19 2 (2007) 142-147
16. Perruccio K., Tosti A., Burchielli E., Topini F., Ruggeri L., Carotti A., et al. Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood 106 (2005) 4397-4406